FibriCheck vs PMcardio

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Qompium nv
VS
by Powerful Medical

AI Verdict

FibriCheck focuses on remote heart rhythm monitoring for arrhythmia detection using smartphone PPG technology, making it ideal for ongoing patient self-monitoring and early detection of conditions like AFib. PMcardio, on the other hand, is an AI platform designed for rapid and accurate interpretation of 12-lead ECGs by healthcare professionals, assessing over 50 cardiac conditions at the point of care. While both are cardiology AI tools, FibriCheck is geared towards continuous patient-centric monitoring, whereas PMcardio is a diagnostic aid for clinicians interpreting standard ECGs.

Choose FibriCheck if…

Choose FibriCheck if you need a convenient, smartphone-camera based solution for long-term, intermittent heart rhythm monitoring, particularly for detecting and managing atrial fibrillation (AF) and other arrhythmias. It's ideal for patients at risk of AF, those monitoring palpitations, or individuals requiring post-procedural rhythm tracking, offering a device-free approach that integrates into existing remote patient monitoring programs and supports early detection and management of chronic conditions.

View FibriCheck →

Choose PMcardio if…

Choose PMcardio if you require rapid, expert-level interpretation of 12-lead ECGs for the assessment of over 50 cardiac conditions, especially in acute care settings like emergency medicine, cardiology, and primary care. It's best suited for healthcare professionals who need immediate, accurate AI-powered diagnostics for conditions such as STEMI/OMI and reduced LVEF, enabling confident clinical decision-making and streamlined patient triage at the point of care.

View PMcardio →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature FibriCheck PMcardio
Pricing Available via subscription for end-users (monthly/yearly) or through licensing agreements for healthcare providers and clinical centers. Freemium
Deployment Cloud-based digital application Mobile app (iOS and Android), Web platform, Enterprise integrations with EHR/CVIS and EMS systems
FDA Status 1 AI-estimated Pending AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

FibriCheck

FibriCheck is designed for patients to monitor their heart rhythm using a smartphone camera, making it highly accessible and user-friendly for individuals at home. Studies indicate high patient satisfaction and ease of use, with 97% finding installation and use easy. PMcardio, while also available as a mobile app, is primarily for healthcare professionals interpreting ECGs, which implies a more complex interface and workflow for clinical use.

Clinical Value

PMcardio

PMcardio offers a broader range of diagnostic capabilities, interpreting over 50 cardiac conditions from ECGs, including critical conditions like STEMI/OMI and reduced LVEF. It has been clinically validated in more than 25 studies, demonstrating superior accuracy over standard-of-care methods for certain conditions. FibriCheck focuses primarily on detecting and monitoring Atrial Fibrillation (AFib) and other arrhythmias using PPG technology, with its algorithm validated in various studies for high sensitivity and specificity in AF detection.

Pricing & Value

PMcardio

PMcardio offers a freemium model with a free plan that includes 5 ECG analyses per month, allowing users to experience its core features before committing financially. FibriCheck's pricing is subscription-based for end-users, with monthly or yearly options, and also offers per-measurement fees for expert review, which could accumulate costs. While both offer value, PMcardio's free tier provides a significant advantage for initial adoption and evaluation.

Enterprise Readiness

PMcardio

PMcardio is explicitly designed for enterprise integrations, connecting with EHR/CVIS and EMS systems, and offering features like centralized access to ECGs, configurable user permissions, and robust security. It provides a unified AI platform for system-wide cardiac care. FibriCheck offers a healthcare professional portal for patient monitoring and licensing agreements for providers, but its enterprise integration capabilities appear less extensive and less explicitly detailed than PMcardio's.

Innovation

PMcardio

PMcardio demonstrates strong innovation with its AI explainability feature (ECGxplainu2122) using heatmaps, and specialized AI models like 'Queen of Hearts' for STEMI/OMI detection and 'LVsense' for reduced LVEF. It also boasts a broader scope of 50+ cardiac condition detections from ECGs. FibriCheck's innovation lies in its smartphone camera-based PPG technology for heart rhythm monitoring and its FDA clearance for this approach, making cardiac monitoring highly accessible.

Support & Docs

Tie

Both tools offer help centers and user manuals. FibriCheck provides a help center with sections for individuals, healthcare providers, and partners, along with user manuals and FAQs. PMcardio also has a comprehensive help center with instructions for use for individuals and organizations, FAQs, and regulatory documentation. Without specific comparative data on response times or the depth of support channels beyond what is publicly available, it's difficult to definitively declare a winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature FibriCheck PMcardio
Primary Function Medically certified app for heart rhythm monitoring to detect and monitor arrhythmias using a smartphone camera. CE-certified AI platform that interprets ECGs to assess over 50 cardiac conditions.
Technology Used Smartphone camera-based PPG technology for heart rhythm measurement, AI-powered algorithm for arrhythmia detection and analysis. AI-powered ECG interpretations, compatible with any 12-lead ECG format (image capture or upload).
Key Detections/Analyses Detection of Atrial Fibrillation (AFib) and other arrhythmias, ability to log blood pressure and weight. Detection of 50+ ECG findings (including STEMI/OMI, rhythms, reduced LVEF, conduction disorders), automatic analysis of heart rate, axis, P wave, PR, QRS, and QT/QTc intervals, Culprit Artery AI confidence scores with 3D heart visualization.
Clinical Validation Clinically validated and FDA-cleared with 99% accuracy compared to gold-standard ECG in a clinical trial. Backed by over 100 peer-reviewed publications. Clinically validated in more than 25 studies and trusted by over 100,000 clinicians. Outperformed standard-of-care methods, delivering 2x sensitivity for early STEMI detection and reducing false STEMI alarms by over 60%. Identifies atrial fibrillation (and other arrhythmias) with 98.3% accuracy.

Videos

Demos, reviews, and walkthroughs featuring FibriCheck and PMcardio.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

FibriCheck focuses on remote heart rhythm monitoring for arrhythmia detection, particularly Atrial Fibrillation (AFib), using a smartphone camera (PPG technology) for ongoing patient management. PMcardio, on the other hand, is an AI platform that interprets 12-lead ECGs to assess over 50 cardiac conditions, providing rapid, expert-level interpretations at the point of care for a broader range of diagnoses, including STEMI and reduced LVEF.
FibriCheck demonstrates high overall performance for AF detection, with reported accuracy exceeding 98%, sensitivity of 96.3-100%, and specificity of 95.8-99.3%. PMcardio shows good diagnostic accuracy for major ECG abnormalities with 86% sensitivity and 92% specificity, and near-perfect properties for diagnosing AF, with 97% sensitivity and 99% specificity.
FibriCheck is designed for seamless integration into clinical workflows, allowing patients to monitor at home and providers to access rhythm trends and export EHR-compatible reports via a clinical portal. PMcardio offers enterprise integrations with EHR/CVIS and EMS systems, aiming to connect across existing systems without replacing them and providing a unified cardiac AI platform for multi-pathway, multi-site cardiac care delivery.
FibriCheck emphasizes ease of use for patients, who can be easily trained to use the app, and physicians can remotely review data, suggesting a straightforward learning curve for both. PMcardio's mobile and web app allows teams to start using AI-powered ECG interpretation immediately without IT integration, implying a relatively low barrier to entry for individual clinicians, though successful adoption in clinical practice will require integration into existing workflows.
PMcardio is built for regulated healthcare environments with SOC 2 Type II and ISO 27001 certifications, supporting regional data residency, role-based access control, SSO, and full audit trails. FibriCheck's documentation and reporting are designed for compliance and to support reimbursement, and it offers an integration guide covering API architecture, FHIR compatibility, SSO, identity management, and data governance.
FibriCheck is particularly beneficial for early detection of irregular heart rhythms, investigating and monitoring palpitations, catching recurrences early after cardiac procedures, and managing heart rhythm conditions between visits, especially for remote patient monitoring. PMcardio is designed for instant, AI-powered ECG analysis at the point of care, empowering various healthcare professionals in emergency medicine, general practice, and cardiology to rapidly assess over 50 cardiac conditions, including critical ones like STEMI, and can significantly cut door-to-balloon times.

Backers

Who funded each tool's parent company.

PMcardio

AI Tool Finder
AI-powered search. Results may not be comprehensive.